Miguel Regueiro, MD, Chair of Cleveland Clinic’s Department of Gastroenterology, Hepatology and Nutrition, highlights six can’t-miss DDW presentations by our researchers.
A new study presented at ACG 2018 helps make the argument for ESD en-bloc resection of high-risk polyps. It shows that with a select patient population, this type of resection may be truly beneficial and worth the extra effort. Dr. Amit Bhatt explains.
Unable to be operated on at her local hospital, a 59-year-old with a 7 cm esophageal squamous cell cancer undergoes ESD and remains cancer-free.
An in-depth look at the current indications for endoscopic submucosal dissection in the evaluation and treatment of patients with early gastrointestinal neoplasms.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Why endoscopic submucosal dissection is an important tool that advanced endoscopists should probably use a lot.
A look at why hydroxyethyl starch is the best pick of seven common fluids used as injectate during ESD in the U.S. Dr. Amit Bhatt explains the findings.
Endoscopic submucosal dissection, a technique pioneered in Japan, is offering a less invasive alternative to surgery for patients with early gastrointestinal tumors.
From single-port to endoscopy/laparoscopy to robotics, Cleveland Clinic’s minimally invasive surgery team brings the most advanced techniques to colorectal surgery patients.
By combining laparoscopy and endoscopy, the Digestive Disease Institute’s new Developmental Endoscopy Group is now able to provide new minimally invasive options to patients for motility disorders and GI cancers.
ESD is being used at a handful of U.S. centers to remove large colonic polyps. Discover more about this approach, which may soon be more widely adopted by surgeons and endoscopists.